Tobacco Cessation Strategies for Smoking
Trial Summary
What is the purpose of this trial?
This trial aims to connect tobacco using patients of Community Health Centers (CHCs) and Federally Qualified Health Centers (FQHCs) with evidence-based treatment to help them quit. The trial will evaluate multiple strategies, that target both clinics and for patients, to increase the number of patients who enroll in Utah Tobacco Quit Line treatment.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Tobacco Cessation Strategies for Smoking?
Research shows that using electronic health records (EHR) to track smoking status and provide smoking cessation support can significantly increase the number of patients assessed for tobacco use, as seen in a cancer center where assessments rose from 48% to 90%. Additionally, telephone counseling has been found to be an effective aid for quitting smoking, offering benefits beyond routine clinician intervention.12345
Is the Tobacco Cessation Strategies for Smoking treatment safe for humans?
The research articles reviewed do not provide specific safety data for the Tobacco Cessation Strategies for Smoking treatment, but they do not report any safety concerns related to the interventions studied, such as electronic health record tools, episodic future thinking, or telephone-based support.678910
How does this treatment for smoking cessation differ from other treatments?
Research Team
David Wetter
Principal Investigator
Huntsman Cancer Institute/ University of Utah
Eligibility Criteria
This trial is for current tobacco users who visit Community Health Centers or Federally Qualified Health Centers. Participants must have a working cellphone, be able to receive texts and calls, and speak English or Spanish.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Clinic-Level Intervention
Clinics receive the AAC intervention to facilitate tobacco cessation through EHR alerts
Phase I (Patient-Level)
Patients receive either text messages or continue with EHR intervention for 6 months
Phase II (Patient-Level)
Nonresponders receive continued text messages and/or telephone coaching for 6-12 months
Follow-up
Participants are monitored for abstinence and quality of life at 12 months
Treatment Details
Interventions
- Electronic Health Record intervention
- Smoking Cessation Intervention
- Telephone-Based Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Utah
Lead Sponsor
Patient-Centered Outcomes Research Institute
Collaborator